Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05377528
What this trial is testing

Study of AGEN1571 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Agenus Inc. 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT03228667
What this trial is testing

QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors

Who this might be right for
Non-Small Cell Lung CancerSmall Cell Lung CancerUrothelial Carcinoma+10 more
ImmunityBio, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT05673577
What this trial is testing

Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC Patients

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Fudan University 41
Testing effectiveness (Phase 2)Looking for participantsNCT06647680
What this trial is testing

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

Who this might be right for
Rectal Cancer Patients
The Affiliated Hospital of Qingdao University 35
Early research (Phase 1)Study completedNCT03790488
What this trial is testing

Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies

Who this might be right for
Cancer
Jounce Therapeutics, Inc. 18
Early research (Phase 1)Ended earlyNCT03294694
What this trial is testing

Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer

Who this might be right for
Metastatic Hormone-Receptor-Positive (HR+) Breast CancerHER2-Negative Breast CancerMetastatic Epithelial Ovarian Cancer
Dana-Farber Cancer Institute 33
Testing effectiveness (Phase 2)Looking for participantsNCT04271956
What this trial is testing

Efficacy and Safety of Zanubrutinib Plus Tislelizumab Treatment With or Without Sonrotoclax for Patients With Richter Transformation

Who this might be right for
Richter Transformation
German CLL Study Group 83
Not applicableUnknownNCT04860076
What this trial is testing

Open-label, Uncontrolled, Non-Interventional, Retrospective Study to Evaluate Molecular Determinants of Outcome to the Immune Checkpoint Inhibitors (Anti-PD-1/Anti-PD-L1 Monoclonal Antibodies) Treatment for Solid Tumors

Who this might be right for
MelanomaLung Cancer
Asylia Diagnostics BV 400
Testing effectiveness (Phase 2)Study completedNCT03331562
What this trial is testing

A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreas AdenocarcinomaAdvanced Pancreatic Cancer+2 more
Translational Genomics Research Institute 24
Testing effectiveness (Phase 2)Study completedNCT05505825
What this trial is testing

AK104 in Combination With Chiauranib in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
SCLC,Extensive Stage
Akeso 36
Not applicableUnknownNCT04471480
What this trial is testing

TC Plus PD-1 Inhibitors Combined With Anlotinib for Advanced Advanced Esophageal Cancer

Who this might be right for
ESCC
Dong Wang 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07385989
What this trial is testing

Golidocitinib Combined With P-GemOx Plus PD-1 Inhibitor Versus P-GemOx Plus PD-1 Inhibitor in First-Line Newly Diagnosed Advanced or Non-Nasal Extranodal NK/T-Cell Lymphoma

Who this might be right for
Extranodal NK/T-cell Lymphoma
WEI XU 40
Testing effectiveness (Phase 2)Ended earlyNCT05935748
What this trial is testing

Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)

Who this might be right for
ccRCCClear Cell Renal Cell CarcinomaKidney Cancer+18 more
NiKang Therapeutics, Inc. 18
Testing effectiveness (Phase 2)UnknownNCT05290935
What this trial is testing

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial

Who this might be right for
Recurrent Cervical CarcinomaPersistent Advanced Cervical CarcinomaChemotherapy+3 more
Lei Li 122
Not applicableLooking for participantsNCT07829081
What this trial is testing

Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient Early-stage GI Tumors

Who this might be right for
Quality of Life (QOL)Mismatch Repair Deficient Colorectal CancerMicrosatellite Instability-High Colorectal Cancer+8 more
University Hospital, Basel, Switzerland 234
Testing effectiveness (Phase 2)Active Not RecruitingNCT04659811
What this trial is testing

Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma

Who this might be right for
Grade I Meningioma, AdultGrade II Meningioma, AdultGrade III Meningioma, Adult+1 more
Nancy Ann Oberheim Bush, MD 35
Not applicableLooking for participantsNCT06190275
What this trial is testing

Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck Tumors

Who this might be right for
HNSCC
Grit Biotechnology 32
Not applicableLooking for participantsNCT07354971
What this trial is testing

IMMUNO-FIT Observational Study

Who this might be right for
NeoplasmsImmunotherapyPhysical Fitness+2 more
University Hospital Southampton NHS Foundation Trust 67
Early research (Phase 1)Study completedNCT03910530
What this trial is testing

INCMGA00012, INCB001158, and the Combination in Japanese Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Solid Tumors
Incyte Biosciences Japan GK 18
Large-scale testing (Phase 3)Looking for participantsNCT03949231
What this trial is testing

Infusion of PD1/PDL1/CTLA4 Inhibitors Via Hepatic Arterial for Immunotherapy of Hepatocellular Carcinoma

Who this might be right for
Liver Cancer
Second Affiliated Hospital of Guangzhou Medical University 200
Next Page